Study Evaluating Venlafaxine ER in Recurrent Depression

NCT00046020 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

1096

Enrollment

INDUSTRY

Sponsor class

Conditions

Depressive Disorder, Major
Recurrence

Interventions

DRUG: Venlafaxine ER

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer